Clinical trial
A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia
NCT03260920 is registered in ClinicalTrials.gov with London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Clinical Trial of Intranasal Oxytocin for Frontotemporal Dementia
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2018
- Completion date
- December 31, 2024
- Enrollment
- 112 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.